Retraction: Efficacy and safety of tripterygium glycosides for active moderate to severe Graves’ ophthalmopathy: a randomised, observer-masked, single-centre trial

in European Journal of Endocrinology
View More View Less
  • 1 Department of Endocrinology, Jinling Hospital
  • 2 Department of Endocrinology, Taikang Xianlin Drum Tower Hospital, Nanjing, Jiangsu Province, China

Correspondence should be addressed to J Shao or J Wang; Email: shaojiaq@hotmail.com or wangjndcrn@126.com

This article has been retracted at the request of the authors:

Ye X, Zhao H, Liu J, Lu B, Shao J & Wang J. Efficacy and safety of tripterygium glycosides for active moderate to severe Graves’ ophthalmopathy: a randomised, observer-masked, single-centre trial. European Journal of Endocrinology 184 277–287. (https://doi.org/10.1530/EJE-20-0857)

The article has been retracted after the discovery of a serious error with the data used in the analysis which rendered the results and conclusions of this article invalid. As such, and with agreement from all authors, the article has now been retracted.

This request to retract the article was received on 9 March 2021 and the retraction notice was published on 12 March 2021.

 

     European Society of Endocrinology

Sept 2018 onwards Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 149 149 148
PDF Downloads 145 145 145